Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3506 |
Nazartinib
那扎替尼,EGF816,NVS-816 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Nazartinib (EGF816) 是一种共价、不可逆、突变选择性 EGFR 抑制剂,对激活 mt (L858R, ex19del) 和 T790M mt 具有纳摩尔抑制效力,在体外其选择性比野生型 (wt) EGFR 高 60 倍。 | |||
T11156L |
Nazartinib mesylate
EGF816 (mesylate) |
Others | Others |
Nazartinib mesylate is a novel, covalent mutant-selective inhibitor of EGFR (Ki and Kinact: 31 nM and 0.222/min on EGFR(L858R/790M) mutant). | |||
T11156 |
Nazartinib S-enantiomer
EGF816 (S-enantiomer) |
Others | Others |
Nazartinib is an EGFR inhibitor. Nazartinib S-enantiomer is the less active S-enantiomer of Nazartinib. |